Published in J Clin Invest on May 01, 2000
Cardiac remodeling in obesity. Physiol Rev (2008) 2.95
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics (2009) 2.36
BTBR Ob/Ob mutant mice model progressive diabetic nephropathy. J Am Soc Nephrol (2010) 2.16
Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest (2003) 1.95
Protein tyrosine phosphatase 1B, a major regulator of leptin-mediated control of cardiovascular function. Circulation (2009) 1.70
Leptin modulates the effects of acyl CoA:diacylglycerol acyltransferase deficiency on murine fur and sebaceous glands. J Clin Invest (2002) 1.58
Hypertension and impaired renal function accompany juvenile obesity: the effect of prenatal diet. Kidney Int (2007) 1.56
Mouse models of the metabolic syndrome. Dis Model Mech (2010) 1.55
Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res (2015) 1.45
PTG gene deletion causes impaired glycogen synthesis and developmental insulin resistance. J Clin Invest (2003) 1.27
Selective leptin resistance revisited. Am J Physiol Regul Integr Comp Physiol (2013) 1.21
Mechanisms mediating renal sympathetic activation to leptin in obesity. Am J Physiol Regul Integr Comp Physiol (2008) 1.20
Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia. Reprod Biol Endocrinol (2011) 1.18
A brain leptin-renin angiotensin system interaction in the regulation of sympathetic nerve activity. Am J Physiol Heart Circ Physiol (2012) 1.14
Effects of nasal CPAP treatment on insulin resistance, lipid profile, and plasma leptin in sleep apnea. Lung (2009) 1.07
Nondiabetic consequences of obesity on kidney. Pediatr Nephrol (2006) 1.07
Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications. Hypertens Res (2011) 1.06
Low-carbohydrate/high-fat diet attenuates pressure overload-induced ventricular remodeling and dysfunction. J Card Fail (2008) 1.06
Ghrelin, leptin, adiponectin, and resistin levels in sleep apnea syndrome: Role of obesity. Ann Thorac Med (2010) 1.03
Diet-induced obesity in rats leads to a decrease in sperm motility. Reprod Biol Endocrinol (2011) 1.02
Impact of leptin-mediated sympatho-activation on cardiovascular function in obese mice. Hypertension (2011) 1.02
Adiponectin in cardiovascular inflammation and obesity. Int J Inflam (2011) 1.01
Leptin receptor polymorphisms and lung function decline in COPD. Eur Respir J (2009) 1.00
Brain-derived neurotrophic factor (BDNF) in the hypothalamic ventromedial nucleus increases energy expenditure. Brain Res (2010) 0.99
Differential effects of insulin on sympathetic nerve activity in agouti obese mice. J Hypertens (2010) 0.98
Investigating Susceptibility to Diabetes Using Features of the Adipose Tissue in Response to In Utero Polycyclic Aromatic Hydrocarbons Exposure. Diabetes Metab J (2016) 0.91
Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome. Thorax (2002) 0.91
Control of metabolic and cardiovascular function by the leptin-brain melanocortin pathway. IUBMB Life (2013) 0.90
Diabetes and cardiovascular autonomic dysfunction: application of animal models. Auton Neurosci (2008) 0.90
Cardiovascular and sympathetic effects of disrupting tyrosine 985 of the leptin receptor. Hypertension (2011) 0.89
Characterization of a new animal model of metabolic syndrome: the DahlS.Z-Lepr(fa)/Lepr(fa) rat. Nutr Diabetes (2011) 0.89
The lack of cardiotrophin-1 alters expression of interleukin-6 and leukemia inhibitory factor mRNA but does not impair cardiac injury response. Cytokine (2006) 0.85
Neuro-endocrine regulation of blood pressure. Indian J Endocrinol Metab (2011) 0.84
Chronic kidney disease, obesity, and hypertension: the role of leptin and adiponectin. Int J Hypertens (2012) 0.84
Cardiovascular changes in animal models of metabolic syndrome. J Diabetes Res (2013) 0.83
The role of novel biomarkers of cardiovascular disease in chronic kidney disease: focus on adiponectin and leptin. Curr Cardiol Rev (2008) 0.83
A Prospective Study of Fatty Liver Index and Incident Hypertension: The KoGES-ARIRANG Study. PLoS One (2015) 0.82
PI3K signaling: A key pathway in the control of sympathetic traffic and arterial pressure by leptin. Mol Metab (2013) 0.82
Fenugreek seed extract inhibit fat accumulation and ameliorates dyslipidemia in high fat diet-induced obese rats. Biomed Res Int (2014) 0.81
Effects of CP-900691, a novel peroxisome proliferator-activated receptor α, agonist on diabetic nephropathy in the BTBR ob/ob mouse. Lab Invest (2014) 0.81
Effects of leptin on cardiovascular physiology. J Am Soc Hypertens (2010) 0.80
Elevated serum leptin levels in patients with acute myocardial infarction; correlation with coronary angiographic and echocardiographic findings. BMC Res Notes (2012) 0.80
Renal hemodynamic and morphological changes after 7 and 28 days of leptin treatment: the participation of angiotensin II via the AT1 receptor. PLoS One (2015) 0.79
Pressure mediated hypertrophy and mechanical stretch up-regulate expression of the long form of leptin receptor (ob-Rb) in rat cardiac myocytes. BMC Cell Biol (2012) 0.79
Polymorphisms in the 3'UTR of the human leptin gene and their role in hypertension. Mol Med Rep (2012) 0.79
Resistin, an Adipokine with Non-Generalized Actions on Sympathetic Nerve Activity. Front Physiol (2015) 0.78
Leptin Induces Hypertension and Endothelial Dysfunction via Aldosterone-Dependent Mechanisms in Obese Female Mice. Hypertension (2016) 0.78
Leptin and the Regulation of Renal Sodium Handling and Renal Na-Transporting ATPases: Role in the Pathogenesis of Arterial Hypertension. Curr Cardiol Rev (2010) 0.78
Analysis of the placental tissue transcriptome of normal and preeclampsia complicated pregnancies. Acta Naturae (2014) 0.77
Leptin increases blood pressure and markers of endothelial activation during pregnancy in rats. Biomed Res Int (2013) 0.77
The association of leptin with dyslipidemia, arterial hypertension and obesity in Kyrgyz (Central Asian nation) population. BMC Res Notes (2014) 0.77
Effects of living at two ambient temperatures on 24-h blood pressure and neuroendocrine function among obese and non-obese humans: a pilot study. Int J Biometeorol (2012) 0.76
Chronic hyperleptinemia results in the development of hypertension in pregnant rats. Am J Physiol Regul Integr Comp Physiol (2015) 0.76
Differential Control of the Sympathetic Nervous System by Leptin: Implications for Obesity. Clin Exp Pharmacol Physiol Suppl (2007) 0.76
Leptin as a Mediator of Obesity-Induced Hypertension. Curr Obes Rep (2016) 0.75
Central Leptin and Tumor Necrosis Factor-α (TNFα) in Diurnal Control of Blood Pressure and Hypertension. J Biol Chem (2016) 0.75
Neuroinflammatory and autonomic mechanisms in diabetes and hypertension. Am J Physiol Endocrinol Metab (2016) 0.75
Positional cloning of the mouse obese gene and its human homologue. Nature (1994) 38.85
Banting lecture 1988. Role of insulin resistance in human disease. Diabetes (1988) 33.22
Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med (1996) 16.98
Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell (1997) 11.35
Identification and expression cloning of a leptin receptor, OB-R. Cell (1995) 9.74
Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med (1995) 8.51
Role of leptin in the neuroendocrine response to fasting. Nature (1996) 8.02
Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature (1998) 7.36
Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med (1999) 6.94
Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature (1997) 6.80
Biological action of leptin as an angiogenic factor. Science (1998) 6.02
Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med (1995) 5.45
Adipogenesis and obesity: rounding out the big picture. Cell (1996) 5.15
Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA (1999) 4.71
Molecular characterization of the mouse agouti locus. Cell (1992) 4.55
Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci U S A (1997) 3.81
Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature (1994) 3.70
The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature (1995) 3.67
Identification of targets of leptin action in rat hypothalamus. J Clin Invest (1996) 3.49
Leptin receptor missense mutation in the fatty Zucker rat. Nat Genet (1996) 3.35
The relation of adiposity to blood pressure and development of hypertension. The Framingham study. Ann Intern Med (1967) 3.05
Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest (1997) 2.98
Transient increase in obese gene expression after food intake or insulin administration. Nature (1995) 2.79
Chronic leptin infusion increases arterial pressure. Hypertension (1998) 2.78
Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation. Genes Dev (1993) 2.67
Leptin, the product of Ob gene, promotes angiogenesis. Circ Res (1998) 2.63
Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc Natl Acad Sci U S A (1997) 2.57
The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med (1989) 2.51
The molecular genetics of rodent single gene obesities. J Biol Chem (1997) 2.32
Role of leptin in fat regulation. Nature (1996) 2.11
Unraveling the central nervous system pathways underlying responses to leptin. Nat Neurosci (1998) 2.08
Melanocortin receptors in leptin effects. Nature (1997) 2.01
Laboratory animals exhibiting obesity and diabetes syndromes. Metabolism (1977) 1.93
Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension (1999) 1.82
Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes (1996) 1.79
Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes (1997) 1.66
Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene. J Clin Invest (1994) 1.60
Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin. Diabetes (1999) 1.55
Leptin increases uncoupling protein expression and energy expenditure. Am J Physiol (1997) 1.55
General survey of diabetic features of yellow KK mice. Endocrinol Jpn (1970) 1.44
Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system. Neurosci Lett (1998) 1.29
Molecular cloning of rat leptin receptor isoform complementary DNAs--identification of a missense mutation in Zucker fatty (fa/fa) rats. Biochem Biophys Res Commun (1996) 1.27
The Zucker fatty rat as a genetic model of obesity and hypertension. Hypertension (1989) 1.21
Sympathetic activation of leptin via the ventromedial hypothalamus: leptin-induced increase in catecholamine secretion. Diabetes (1999) 1.17
High plasma immunoreactive leptin level in essential hypertension. Am J Hypertens (1997) 1.10
Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat. Nat Genet (1996) 1.06
Leptin-induced increase in sympathetic nervous and cardiovascular tone is mediated by proopiomelanocortin (POMC) products. Brain Res Bull (1999) 1.00
The arcuate nucleus as a primary site of satiety effect of leptin in rats. Neurosci Lett (1997) 0.99
State-of-the-art-lecture: Obesity-induced hypertension: new concepts from the emerging biology of obesity. Hypertension (1999) 0.98
Obesity, metabolism, and the sympathetic nervous system. Am J Hypertens (1989) 0.96
Improvement of insulin sensitivity contributes to blood pressure reduction after weight loss in hypertensive subjects with obesity. Hypertension (1996) 0.92
Effects of central leptin administration on blood pressure in normotensive rats. Neurosci Lett (1998) 0.88
Leptin receptors in the adrenal medulla of the rat. Am J Physiol (1997) 0.82
Role of sympathetic activity in blood pressure reduction with low calorie regimen. Hypertension (1991) 0.81
Obesity due to high fat diet decreases the sympathetic nervous and cardiovascular responses to intracerebroventricular leptin in rats. Brain Res Bull (1998) 0.81
Diminished epinephrine excretion in genetically obese (ob/ob) mice and monosodium glutamate-treated rats. Int J Obes Relat Metab Disord (1992) 0.81
Food restriction reduces sympathetic support of blood pressure in spontaneously hypertensive rats. J Nutr (1997) 0.81
Increased NPY activity in the PVN contributes to food-restriction induced reductions in blood pressure in aortic coarctation hypertensive rats. Brain Res (1999) 0.80
Cardiorespiratory responses to intracerebroventricular injection of neuropeptide Y in anaesthetised dogs. Regul Pept (1999) 0.77
Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity (2000) 10.34
A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell (1998) 8.10
In vitro and in vivo antibacterial activity of T-1220, a new semisynthetic penicillin. Antimicrob Agents Chemother (1977) 7.35
Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature (2000) 7.15
PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science (1996) 6.56
Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc Natl Acad Sci U S A (1996) 6.04
Calcium induced release of calcium from the sarcoplasmic reticulum of skinned skeletal muscle fibres. Nature (1970) 5.65
p140mDia, a mammalian homolog of Drosophila diaphanous, is a target protein for Rho small GTPase and is a ligand for profilin. EMBO J (1997) 5.03
Complete nucleotide sequence of the genome of bovine leukemia virus: its evolutionary relationship to other retroviruses. Proc Natl Acad Sci U S A (1985) 4.68
STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J (1999) 4.55
A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc Natl Acad Sci U S A (1999) 4.46
Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat Genet (1994) 4.36
A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell (1994) 4.35
Re-examination of the apparent binding constant of ethylene glycol bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid with calcium around neutral pH. J Biochem (1980) 3.91
Apg10p, a novel protein-conjugating enzyme essential for autophagy in yeast. EMBO J (1999) 3.70
Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest (1991) 3.70
Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells (1999) 3.69
Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell (1994) 3.66
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation (1994) 3.63
ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett (1996) 3.46
T-786-->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation (1999) 3.41
Cardiovascular anomaly, impaired actin bundling and resistance to Src-induced transformation in mice lacking p130Cas. Nat Genet (1998) 3.38
Crystal structure of transforming growth factor-beta 2: an unusual fold for the superfamily. Science (1992) 3.36
Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med (1997) 3.35
Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab (2001) 3.16
Diversification of Escherichia coli genomes: are bacteriophages the major contributors? Trends Microbiol (2001) 3.08
Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer (1996) 2.96
Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int (2007) 2.93
Cranial and cardiac neural crest defects in endothelin-A receptor-deficient mice. Development (1998) 2.92
The R-type pyocin of Pseudomonas aeruginosa is related to P2 phage, and the F-type is related to lambda phage. Mol Microbiol (2000) 2.77
Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med (1991) 2.75
Identification and characterization of polycystin-2, the PKD2 gene product. J Biol Chem (1999) 2.74
Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells (1997) 2.72
Homeless and housed families in Los Angeles: a study comparing demographic, economic, and family function characteristics. Am J Public Health (1990) 2.71
Rac1 is required for the formation of three germ layers during gastrulation. Oncogene (1998) 2.61
Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc Natl Acad Sci U S A (2000) 2.58
K-ras is essential for the development of the mouse embryo. Oncogene (1997) 2.57
Expression of the Fas ligand in cells of T cell lineage. J Immunol (1995) 2.54
Are aortic aneurysms caused by atherosclerosis? Circulation (1992) 2.52
Interleukin 7 production and function in stromal cell-dependent B cell development. J Exp Med (1989) 2.49
Biosynthesis of xyloglucan in suspension-cultured soybean cells. Occurrence and some properties of xyloglucan 4-beta-D-glucosyltransferase and 6-alpha-D-xylosyltransferase. J Biol Chem (1981) 2.46
Complete nucleotide sequences of 93-kb and 3.3-kb plasmids of an enterohemorrhagic Escherichia coli O157:H7 derived from Sakai outbreak. DNA Res (1998) 2.43
Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab (2000) 2.43
Murine homolog of SALL1 is essential for ureteric bud invasion in kidney development. Development (2001) 2.42
Takayasu's arteritis. Clinical report of eighty-four cases and immunological studies of seven cases. Circulation (1967) 2.42
Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days. Circulation (2001) 2.38
Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension (1996) 2.37
Musashi1: an evolutionally conserved marker for CNS progenitor cells including neural stem cells. Dev Neurosci (2000) 2.36
A clinicopathologic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies: TTF-1 is expressed in both round and surface cells, suggesting an origin from primitive respiratory epithelium. Am J Surg Pathol (2000) 2.35
Endoscopic ultrasound-guided celiac ganglia neurolysis vs. celiac plexus neurolysis: a randomized multicenter trial. Endoscopy (2013) 2.34
Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis. Gastroenterology (2001) 2.30
Islets-activating protein (IAP) in Bordetella pertussis that potentiates insulin secretory responses of rats. Purification and characterization. J Biochem (1978) 2.26
The apparent binding constant of glycoletherdiaminetetraacetic acid for calcium at neutral pH. J Biochem (1968) 2.23
Ca,P-rich layer formed on high-strength bioactive glass-ceramic A-W. J Biomed Mater Res (1990) 2.22
Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice. Kidney Int (2007) 2.21
Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals. J Clin Invest (1991) 2.18
A cytoskeleton-related gene, uso1, is required for intracellular protein transport in Saccharomyces cerevisiae. J Cell Biol (1991) 2.17
Sequence variation in the thermostable direct hemolysin-related hemolysin (trh) gene of Vibrio parahaemolyticus. Appl Environ Microbiol (1992) 2.16
Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology (1993) 2.15
Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. J Clin Invest (1995) 2.15
Acute Wernicke's encephalopathy: comparison of magnetic resonance images and autopsy findings. Intern Med (1996) 2.14
A new computer-assisted method for measuring the tibio-femoral angle in patients with osteoarthritis of the knee. Osteoarthritis Cartilage (2004) 2.11
mGluR1 in cerebellar Purkinje cells essential for long-term depression, synapse elimination, and motor coordination. Science (2000) 2.09
New ultrathin-walled endotracheal tube with a novel laryngeal seal design. Long-term evaluation in sheep. Anesthesiology (1996) 2.08
Reaction of sevoflurane and its degradation products with soda lime. Toxicity of the byproducts. Anesthesiology (1992) 2.07
Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation (1996) 2.06
Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology (1992) 2.06
toxB gene on pO157 of enterohemorrhagic Escherichia coli O157:H7 is required for full epithelial cell adherence phenotype. Infect Immun (2001) 2.04
Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation (1993) 2.04
Biological properties of islets-activating protein (IAP) purified from the culture medium of Bordetella pertussis. J Biochem (1978) 2.02
The internal biliary fistula--reappraisal of incidence, type, diagnosis and management of 33 consecutive cases. HPB Surg (1997) 2.00
Serum leptin level is a regulator of bone mass. Proc Natl Acad Sci U S A (2004) 1.99
Dwarfism and early death in mice lacking C-type natriuretic peptide. Proc Natl Acad Sci U S A (2001) 1.99
Some properties of fragmented frog sarcoplasmic reticulum with particular reference to its response to caffeine. J Biochem (1970) 1.98
Complete DNA sequence and structural analysis of the enteropathogenic Escherichia coli adherence factor plasmid. Infect Immun (1999) 1.98
Depletion of Ca2+ in the sarcoplasmic reticulum stimulates Ca2+ entry into mouse skeletal muscle fibres. J Physiol (2001) 1.97
Polymerization polarity of actin. J Mechanochem Cell Motil (1976) 1.97
Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes (2001) 1.94